About Dr Sherry Wu

Dr Sherry Wu obtained her PhD from the University of Queensland. She then undertook the TRIUMPH postdoctoral translational research fellowship at M.D. Anderson Cancer Centre. She has strong knowledge in target discovery using large-scale experimental and patient databases, in vitro and in vivo validation models, nanotechnology, and molecular biology techniques for studying mechanisms of action and resistance. Her research focuses on: 1) Developing strategies to overcome immune suppression in ovarian and breast cancers; 2) Developing novel strategies to enhance patient survival in ovarian cancer; 3) Developing novel nanoparticle platforms for tumour-targeted delivery; and 4) Early detection of ovarian cancer.

Project: Re-activating anti-tumour immunity by targeting N-MYC-Let7 axis in ovarian cancer